Cell & Gene Therapy

Explore news and insight around cell and gene therapy, including new technology and information in this evolving biotech field. Read on to understand how the industry is addressing gene therapy and cell therapy research and development.

Brought to you by:
Digitally generated DNA fragment on a dark background
Biotech

Patient put in critical condition by Neurogene gene therapy dies

Neurogene disclosed the adverse event Nov. 11 and said the patient was in critical condition Nov. 18.
Nick Paul Taylor Nov 22, 2024 3:57am
Novartis

Novartis signs $1.1B deal for muscular dystrophy biotech

Nov 21, 2024 8:19am
Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Novartis taps Vyriad’s viral vectors for in vivo T cell editing

Nov 20, 2024 12:00pm
FDA stop sign

Neurogene stops Batten gene therapy after FDA denies request

Nov 19, 2024 6:30am
DNA gene therapy gene editing helix CRISPR

Regenxbio starts pivotal study for DMD gene therapy

Nov 18, 2024 2:24pm
photo of a sign labeled closed on a business window

CSL Behring shuts down California cell and gene therapy R&D site

Nov 18, 2024 8:35am
More News

Neurogene acts as gene therapy puts person in critical condition

Nov 18, 2024 8:33am

DMD gene therapy uses cells to stitch together mRNA in mice

Nov 14, 2024 3:10pm

BMS' CAR-T cracks down on lupus, achieving sustained responses

Nov 14, 2024 10:00am

Allogene abandons leukemia CAR-T plans after Breyanzi approval

Nov 14, 2024 5:59am